These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 530258)

  • 1. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.
    Sjöholm I; Ekman B; Kober A; Ljungstedt-Påhlman I; Seiving B; Sjödin T
    Mol Pharmacol; 1979 Nov; 16(3):767-77. PubMed ID: 530258
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of hepatic cirrhosis on the plasma protein binding of drugs.
    García-Morillas M; Gil-Extremera B; Caracuel-Ruiz MD
    Int J Clin Pharmacol Res; 1984; 4(5):327-33. PubMed ID: 6519849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin.
    Wosilait WD; Ryan MP
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):577-84. PubMed ID: 504792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The location of drug binding sites in human serum albumin.
    Fehske KJ; Müller WE; Wollert U
    Biochem Pharmacol; 1981 Apr; 30(7):687-92. PubMed ID: 7018498
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural requirements for drug binding to site II on human serum albumin.
    Wanwimolruk S; Birkett DJ; Brooks PM
    Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
    Kragh-Hansen U; Brennan SO; Galliano M; Sugita O
    Mol Pharmacol; 1990 Feb; 37(2):238-42. PubMed ID: 2304452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lone tryptophan residue of human serum albumin as part of the specific warfarin binding site. Binding of dicoumarol to the warfarin, indole and benzodiazepine binding sites.
    Fehske KJ; Müller WE; Wollert U; Velden LM
    Mol Pharmacol; 1979 Nov; 16(3):778-89. PubMed ID: 93690
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
    Benkestock K; Edlund PO; Roeraade J
    Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New aspects of free drug concentration determination in human serum with equilibrium dialysis.
    van der Giesen WF; Wilting J
    Methods Find Exp Clin Pharmacol; 1982; 4(6):417-23. PubMed ID: 7144334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fatty acids on two specific drug binding sites on human serum albumin.
    Birkett DJ; Myers SP; Sudlow G
    Mol Pharmacol; 1977 Nov; 13(6):987-92. PubMed ID: 593269
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct and indirect determination of binding constants of drug-protein complexes with microparticles.
    Kober A; Ekman B; Sjöholm I
    J Pharm Sci; 1978 Jan; 67(1):107-9. PubMed ID: 619095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy. Binding of drugs to serum albumin (second of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Mar; 294(10):526-31. PubMed ID: 765821
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasma binding of drugs in chronic renal failure].
    Riant P; Barre J; Albengres E; Lemaire M; Tillement JP
    Nephrologie; 1986; 7(3):89-93. PubMed ID: 3774085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein binding of diazepam and digitoxin in uremic and normal serum.
    Kober A; Sjöholm I; Borgå O; Odar-Cederlöf I
    Biochem Pharmacol; 1979 Apr; 28(7):1037-42. PubMed ID: 444260
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding of drugs to serum albumin (first of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Feb; 294(6):311-6. PubMed ID: 1107839
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography.
    Chen J; Ohnmacht C; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):137-45. PubMed ID: 15282104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.